• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

August 2, 2013 Blood Products Advisory Committee Meeting Draft Agenda

FOOD AND DRUG ADMINISTRATION
Center for Biologics Evaluation and Research
107th Meeting of the Blood Products Advisory Committee

National Institutes of Health
Building 29B
Conference Rooms A and B
Rockville, MD

August 2, 2013

DRAFT AGENDA

Friday, August 2, 2013
10:00 a.m. Call to Order and Opening Remarks
Introduction of Committee
J. Brooks Jackson, M.D.
Chair, BPAC
  Conflict of Interest Statement Bryan Emery, LCDR
Designated Federal Officer, BPAC
  Recognition of Retiring Members
Topic I: Review of the Research Programs in the Laboratory of Molecular Virology,
Division of Emerging and Transfusion Transmitted Diseases (DETTD), OBRR
10:10 a.m. Overview of CBER and OBRR Research Programs Carolyn Wilson, Ph.D.
CBER, FDA
10:30 a.m. Overview of the DETTD Research Program Hira Nakhasi, Ph.D.
OBRR, FDA
10:45 a.m. Overview of the Laboratory of Molecular Virology Indira Hewlett, Ph.D.
OBRR, FDA
  Questions & Answers
11:45 a.m. Break
12:00 p.m. Open Public Hearing
1:00 p.m.   Closed Committee Discussion
1:30 p.m. Adjournment